Back to Journals » Open Access Journal of Clinical Trials » Volume 3 » default

Open Access Journal of Clinical Trials


Archive: Volume 3, 2011

Assessment of the efficacy of first-line antimalarial drugs after 5 years of deployment by the National Malaria Control Programme in Côte d'Ivoire

Offianan AT, Assi SB, Coulibaly A, N'guessan LT, Ako AA, Kadjo FK, San MK, Penali LK

Open Access Journal of Clinical Trials 2011, 3:67-76

Published Date: 11 November 2011

Critical illness outcome study: an observational study of protocols and mortality in intensive care units

Ali NA, Gutteridge D, Shahul S, Checkley W, Sevransky J, Martin GS

Open Access Journal of Clinical Trials 2011, 3:55-65

Published Date: 26 September 2011

Examining the clinical trial feasibility process and its implications for a trial site

Burgess LJ, Sulzer NU

Open Access Journal of Clinical Trials 2011, 3:51-54

Published Date: 9 September 2011

The future of the pharmaceutical, biological and medical device industry

Burgess LJ, Terblanche M

Open Access Journal of Clinical Trials 2011, 3:45-50

Published Date: 7 September 2011

The ADOPT trial (Assessment of Efficacies of Cardiac Resynchronization Therapies (CRT-P/D) for Heart Failure Patients in China): rationale, design, and end-points

Liu B, Yi F, Cai H, Guo W, Li W, Shen M, Xia J, Liu L, Wang H, for the ADOPT Study Steering Committee and Investigators

Open Access Journal of Clinical Trials 2011, 3:35-41

Published Date: 20 June 2011

Phenyramidol in acute conditions of lumbago, integumental pain and musculo-skeletal pain: an open label, noncomparative, multi-center study

Shah H, Shakeel A, Karne N, Patil C, Kewalramani R, Kasodekar V, Dave M

Open Access Journal of Clinical Trials 2011, 3:27-33

Published Date: 10 May 2011

A data-capture system for post-marketing surveillance of drugs that integrates with hospital electronic health records

Yamamoto K, Matsumoto S, Yanagihara K, Teramukai S, Fukushima M

Open Access Journal of Clinical Trials 2011, 3:21-26

Published Date: 29 April 2011

Phase II trial of second-line erlotinib and digoxin for nonsmall cell lung cancer (NSCLC)

Fadi Kayali, Muhamad A Janjua, Damian A Laber, Donald Miller, Goetz H Kloecker

Open Access Journal of Clinical Trials 2011, 3:9-13

Published Date: 6 February 2011

Prospective evidence that HIV lipoatrophy and visceral adiposity are partially independent processes

Handan Wand, Dianne Carey, Alexandra Calmy, et al

Open Access Journal of Clinical Trials 2011, 3:1-7

Published Date: 24 January 2011